Singapore has built a strong base of biomedical R&D capabilities in its public research institutions, namely the Bioinformatics Institute (BII), the Bioprocessing Technology Institute (BTI), the Genome Institute of Singapore (GIS), the Institute of Bioengineering & Nanotechnology (IBN) and the Institute of Molecular and Cell Biology (IMCB). At each of these institutes, the best of research talents from all over the world are engaged in cutting edge research spanning the fields of genomics, molecular biology, bioprocessing, bioinformatics and bioengineering.